Johnson & Johnson (JNJ) rated 85/100 OVR on MarketMVP. Johnson & Johnson combines pharmaceuticals and medical devices. It has raised its dividend for 62 consecutive years — on. Tier: A-Tier (Strong). Revenue: +5%. Beta: 0.45.
Using the MarketMVP OVR system — which translates stocks into sports player ratings for intuitive comparison — JNJ scores 85/100 OVR (A-Tier (Strong)). The three dimensions: Momentum (45/100) reflects recent price and fundamental trends. Stability (92/100) measures earnings consistency and volatility profile. Value (75/100) assesses price relative to fundamentals and sector peers.
JNJ is compared to different athletes depending on which sport lens you use — but the archetype is consistent: Ironman.
What does Johnson & Johnson (JNJ) do?
Johnson & Johnson (JNJ) rated 85/100 OVR on MarketMVP. Johnson & Johnson combines pharmaceuticals and medical devices. It has raised its dividend for 62 consecutive years — on. Tier: A-Tier (Strong). Revenue: +5%. Beta: 0.45.
What sector is JNJ in?
JNJ is classified in the Healthcare sector on MarketMVP. Healthcare companies develop pharmaceuticals, medical devices, and health services.
Is JNJ in the S&P 500?
JNJ (Johnson & Johnson) is a component of the S&P 500 index. The S&P 500 includes the 500 largest US-listed companies by market capitalisation. Inclusion generally indicates a company has met size, liquidity, and profitability criteria.
Who are JNJ's main competitors?
Johnson & Johnson's main competitors include PFE, ABBV, MRK, BMY. In the Healthcare sector, competition is assessed on market share, technology differentiation, pricing power, and customer retention rates.
Is JNJ overvalued?
JNJ has a P/E ratio of 14x and a value score of 75/100 on MarketMVP. A value score above 60 suggests the stock appears reasonably priced relative to its fundamentals and sector peers. Valuation is always relative to growth rate and sector context.
What is JNJ's P/E ratio?
JNJ's P/E ratio is 14x. Trading below the S&P 500 average P/E of approximately 22x suggests relative value. MarketMVP's value score of 75/100 contextualises this P/E against revenue growth and sector peers.
What is JNJ's market cap?
Johnson & Johnson (JNJ) has a market capitalisation of approximately $380B. Market cap above $200B is considered large-cap — generally more stable with lower volatility. Market cap equals the current share price multiplied by the total number of shares outstanding.
How volatile is JNJ stock?
JNJ has a beta of 0.45, which MarketMVP calls the 'Injury Risk Rating'. Beta below 1.0 means the stock moves less than the market — relatively defensive in downturns. Stability score: 92/100.
What is JNJ's beta?
JNJ's beta is 0.45. Beta measures how much a stock moves relative to the overall market. A beta of 0.45 means that historically, for every 1% the market moves, JNJ tends to move approximately 0.45%. Lower beta indicates a more defensive investment that reacts less to market swings.
What is JNJ's dividend?
JNJ pays a dividend with an approximate yield of 3.3%. Dividend-paying stocks return a portion of profits to shareholders each quarter. The yield represents the annual dividend as a percentage of the stock price.
What is JNJ's revenue growth?
Johnson & Johnson reported revenue growth of +5% year-over-year. Single-digit revenue growth is typical for large, mature businesses — steady rather than spectacular.
What is JNJ's OVR rating on MarketMVP?
JNJ is rated 85/100 OVR on MarketMVP — placing it in A-Tier (Strong). The OVR score combines three dimensions: Momentum (45/100), Stability (92/100), and Value (75/100). Think of it like a FIFA or NBA 2K player rating — a 96 OVR is generational, 80-89 is strong, 65-79 is solid rotation, below 65 is speculative.
Which athlete is JNJ most like?
On MarketMVP, JNJ is compared to different athletes depending on your sport: NFL → Frank Gore, NBA → Udonis Haslem, Soccer → Ryan Giggs. The archetype is 'Ironman' — Johnson & Johnson (JNJ) rated 85/100 OVR on MarketMVP. Johnson & Johnson combines pharmaceuticals an
What percentage of a portfolio should be in JNJ?
Position sizing depends on conviction, risk tolerance, and portfolio construction philosophy. As a general framework: A-Tier stocks like JNJ might represent 5-8% of a balanced portfolio if held as a core anchor position. No position sizing recommendation is universal — it depends on your complete portfolio context.
Is JNJ a long-term investment?
Johnson & Johnson has a track record of consistent earnings and a wide competitive moat that has held up over multiple business cycles. Long-term holding suitability depends on whether you believe the competitive position will remain intact over your investment horizon.
What happens to JNJ stock in a recession?
In economic downturns, JNJ's performance would depend on its business characteristics. Stability score of 92/100 and beta of 0.45 suggests relatively defensive behaviour — revenue from Healthcare tends to hold up better than cyclical sectors.
How does JNJ compare to the S&P 500?
JNJ has a MarketMVP OVR of 85/100 placing it in A-Tier — strong performer category. Revenue growth of +5% compares to the S&P 500 average of approximately 7-10% annually. Beta of 0.45 compares to the S&P 500 beta of 1.0 — less volatile.
What is JNJ's price target?
MarketMVP does not publish specific price targets — we are an educational platform, not a financial advisory service. Price targets are published by institutional analysts at investment banks and appear on financial platforms like Bloomberg, Yahoo Finance, and MarketBeat. Our OVR system rates JNJ at 85/100 (A-Tier (Strong)) based on fundamental characteristics rather than price prediction.
What are analysts saying about JNJ?
MarketMVP provides an educational OVR rating of 85/100 for JNJ. For professional analyst ratings and price targets, consult platforms like Bloomberg, Yahoo Finance, Seeking Alpha, or your brokerage's research section. MarketMVP's role is to translate financial characteristics into sports-analogous metrics, not to provide investment advice.
What is JNJ's revenue?
Johnson & Johnson reported year-over-year revenue growth of +5%. Market capitalisation of $380B provides context for the revenue multiple. For specific revenue figures, quarterly earnings reports (10-Q filings) and annual reports (10-K filings) are publicly available on the SEC EDGAR database and the company's investor relations website.
Does JNJ pay a dividend?
JNJ pays a dividend. The approximate current yield is 3.3%. Dividend payments are typically made quarterly. The dividend yield represents annual payments as a percentage of the current stock price.